Search

everythinglearnresearchcommunity

for

Search:↓

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Meloside A may help protect hair cells from damage linked to hair loss.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Testosterone reduces knee flexibility by affecting relaxin receptors.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

VEGF and its receptor might cause hair loss.

AH-001 could be a safer and more effective treatment for hair loss.

Androgens may improve pig reproduction by enhancing ovulation and litter size.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

A new treatment for hair loss shows promise with fewer side effects.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Higher androgen levels and site-specific AR expression cause sex-related skeletal differences, and certain steroids can boost AR expression and androgen effects in bone cells.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

The document concludes that the androgen receptor's structure and function are complex, affecting how it regulates genes and is involved in diseases like prostate cancer.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

CAG repeat polymorphism and prostate zone volume are not reliable markers of long-term androgen sensitivity.

A point mutation in the androgen receptor gene causes complete androgen insensitivity.

Androgens cause oil-producing skin cells with androgen receptors to mature and produce more oil.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Human keratinocytes do not naturally respond to androgens.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.